Article Details
Retrieved on: 2023-01-02 09:17:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Research analysts expect that Kinnate Biopharma will post -2.63 EPS for the current fiscal year. Institutional Investors Weigh In On Kinnate Biopharma ...
Article found on: reporter.am
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here